Lucid Diagnostics Statistics
NASDAQ: LUCDHealth CareMedical/Dental InstrumentsUSD
0.6235+0.0235 (+3.92%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 0.6248 +0.21%
Lucid Diagnostics by the numbers
Lucid Diagnostics has a market capitalization of $119.1 million based on 190.95M shares outstanding. With trailing EPS of $-0.44, Lucid Diagnostics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 29.7% below its 50-day average and 42.4% below its 200-day average.
Average daily trading volume is 1.36M shares, or about $845,063 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
LUCD valuation vs. peer median
| Metric | LUCD | Peer median | Difference |
|---|---|---|---|
| Market cap | $119.06M | $109.38M | +9% |
| Avg. volume | 1.36M | 258.10K | +425% |
Peer median across 8 companies: QTEX, APYX, KRMD, PYPD, NYXH, LNSR, LUNG, STIM.
Valuation
- Market cap
- $119.06M
- EPS (TTM)
- $-0.44
- Shares outstanding
- 190.95M
Price and trading
- Previous close
- 0.60
- Open
- 0.591
- Day range
- 0.5875 – 0.653
- 52-week range
- 0.50 – 1.63
- 52-week change
- -40.62%
- 50-day moving average
- 0.8866
- Beta
- —
- Volume
- 1.70M
- Average volume
- 1.36M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 13, 2026
Additional statistics
- Market Cap
- 119.06M
- Forward Pe
- -3.78
- Eps
- -0.44
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 1.63
- Week52 Low
- 0.50
- Avg Volume
- 1.36M
- Shares Outstanding
- 190.95M
- Ma50
- 0.89
- Ma200
- 1.08
- Earnings Date
- Aug 13, 2026
- Pct From52w High
- -61.72%
- Pct From52w Low
- 24.70%